Related Experiment Video
Updated: May 2, 2026

Prediction and Validation of Gene Regulatory Elements Activated During Retinoic Acid Induced Embryonic Stem Cell Differentiation
Published on: June 21, 2016
Coordinated regulation of retinoic acid signaling pathway by KDM5B and polycomb repressive complex 2
Yu Zhang1, Jing Liang, Qian Li
1Department of Biochemistry and Molecular Biology, Peking University Health Science Center, Beijing, 100191, China.
Abstract:
Polycomb repressive complex 2 (PRC2) is a critical epigenetic regulator in many biological processes, including maintenance of cell identity, stem cell self-renewal, differentiation, and deregulation of PRC2 is often observed in human cancers and diseases. Here we report that KDM5B (PLU-1/JARID1B), a histone lysine demethylase of Jumonji family, associates with PRC2 and colocalizes with PRC2 in nuclear bodies, and their physical association is dependent on direct interaction between KDM5B and the SUZ12 component of PRC2. Interestingly, co-occupancy of KDM5B and PRC2 was evidenced at the conserved cis-regulatory DNA element on retinoic acid (RA) responsive genes. Transcription readout and in vitro pull-down experiments suggest that KDM5B is an essential co-activator, but not a co-repressor, for the RA signaling, and the interface between KDM5B's JMJC domain and retinoic acid receptor α (RARα) is crucial for RA-mediated gene expression. Detailed chromatin immunoprecipitation assays addressed the seemingly paradox by revealing a biphasic effect of KDM5B on RA-induced gene activation through decoupled H3K4me3 demethylation and PRC2-antagonizing activities. These results demonstrate that KDM5B and PRC2 regulate RA signaling cascade in a cooperative and orchestrated fashion.
Insights
KDM5B associates with Polycomb repressive complex 2 (PRC2) to regulate retinoic acid signaling. This interaction is crucial for gene expression, impacting cell identity and disease.
Area of Science:
- Epigenetics
- Molecular Biology
- Gene Regulation
Background:
- Polycomb repressive complex 2 (PRC2) is a key epigenetic regulator involved in cell identity, stem cell renewal, and differentiation.
- Dysregulation of PRC2 is frequently observed in human cancers and various diseases.
- KDM5B, a histone lysine demethylase, is implicated in cellular processes but its interaction with PRC2 was not well understood.
Purpose of the Study:
- To investigate the functional relationship between KDM5B and PRC2.
- To elucidate the role of KDM5B in retinoic acid (RA) signaling.
- To understand the molecular mechanisms underlying KDM5B and PRC2 cooperation in gene regulation.
Main Methods:
- Co-immunoprecipitation and colocalization studies to assess KDM5B-PRC2 interaction.
- In vitro pull-down assays and transcription readout experiments to determine KDM5B's role in RA signaling.
- Chromatin immunoprecipitation (ChIP) assays to analyze KDM5B and PRC2 occupancy and histone modifications (H3K4me3) at target genes.
Main Results:
- KDM5B physically associates with PRC2, specifically interacting with the SUZ12 component, and colocalizes in nuclear bodies.
- KDM5B acts as a co-activator, not a co-repressor, in RA signaling, with its JMJC domain crucial for interaction with retinoic acid receptor α (RARα).
- KDM5B exhibits a biphasic effect on RA-induced gene activation, involving H3K4me3 demethylation and antagonism of PRC2 activity.
Conclusions:
- KDM5B and PRC2 cooperate to regulate the retinoic acid signaling pathway.
- The physical and functional interplay between KDM5B and PRC2 is essential for orchestrated gene expression.
- These findings reveal a novel mechanism of epigenetic regulation in RA signaling with implications for understanding cell identity maintenance and disease.
Related Concept Videos
Co-activators and Co-repressors
Co-activators and Co-repressors
Master Transcription Regulators
Negative Regulator Molecules
Hedgehog Signaling Pathway
RNA Polymerase II Accessory Proteins

